Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation

Lignende værker

• The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
  af: Cao, Fangyuan, et al.
  Udgivet: (2018)
• Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing
  af: Liu, Bin, et al.
  Udgivet: (2020)
• Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs()
  af: Xiao, Yufeng, et al.
  Udgivet: (2020)
• The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression
  af: Ashburner, Brian P., et al.
  Udgivet: (2001)
• Histone deacetylases (HDACs): characterization of the classical HDAC family.
  af: de Ruijter, Annemieke J M, et al.
  Udgivet: (2003)